TaxolTM (Paclitaxel), epirubicin and cyclophosphamide (TEC) in the treatment of metastatic breast cancer (MBC): results of a phase I study

TaxolTM (Paclitaxel), epirubicin and cyclophosphamide (TEC) in the treatment of metastatic breast cancer (MBC): results of a phase I study J-M Nabholtz, K Khoo, JR Mackey, M Smylie, T Al-Tweigeri, D Dudgeon, 0 Keller, 0 Foerster, C Olweny, T Shore, E Sansregret, E Stiles, H Dulude, G Gallant, B Brown Cross Cancer Institute, Edmonton, Alberta: Manitoba Cancer Foundation; Bristol-Myers Squibb, Montreal, Canada